Results 221 to 230 of about 41,794 (337)

Alcohol use disorder and use of rhythm control therapies in patients with atrial fibrillation: A nationwide cohort study. [PDF]

open access: yesInt J Cardiol Heart Vasc
Vanhanen M   +12 more
europepmc   +1 more source

Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy. [PDF]

open access: bronze, 1992
Boaz Avitall   +6 more
openalex   +1 more source

Premature Ventricular Contractions From the Proximal Left Anterior Fascicle: Insight From the Electrophysiologic and Anatomic Parameters

open access: yesJournal of Cardiovascular Electrophysiology, Volume 37, Issue 1, Page 7-16, January 2026.
ABSTRACT Introduction Premature ventricular contractions (PVCs) originating from the proximal left anterior fascicle (LAF) are rarely discussed. We aimed to describe the characteristics and ablation outcome of PVCs originating from the proximal LAF and propose a stepwise approach.
Xuan Hoang Le   +23 more
wiley   +1 more source

New cases expand the genotype, phenotype and therapeutic landscape of H syndrome

open access: yes
British Journal of Haematology, Volume 208, Issue 1, Page 363-366, January 2026.
Clément Triaille   +10 more
wiley   +1 more source

Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy

open access: green, 2017
Hee Tae Yu   +9 more
openalex   +2 more sources

Outcomes of Focused Double Extrastimuli Mapping and Ablation in Ventricular Tachycardia

open access: yesJournal of Cardiovascular Electrophysiology, Volume 37, Issue 1, Page 137-148, January 2026.
ABSTRACT Background Conventional substrate mapping for scar‐related ventricular tachycardia (VT) often fails to fully delineate critical arrhythmogenic components. Functional mapping strategies using extrastimuli have shown promise but are limited by procedural complexity.
Surachat Jaroonpipatkul   +6 more
wiley   +1 more source

The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation. [PDF]

open access: yesArrhythm Electrophysiol Rev, 2015
Clauss S, Sinner MF, Kääb S, Wakili R.
europepmc   +1 more source

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Patients ≥ 80 Years Old With Type 2 Diabetes

open access: yesJournal of the American Geriatrics Society, Volume 74, Issue 1, Page 96-106, January 2026.
Effect of glucagon‐like peptide‐1 receptor agonist therapy on cardiorenal outcomes in patients aged ≥ 80 years with Type 2 diabetes. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated potential in improving glycemic control and reducing adverse outcomes in patients with Type 2 diabetes mellitus (T2DM); however ...
Jui‐Cheng Chen   +4 more
wiley   +1 more source

Early substrate-based catheter ablation vs. antiarrhythmic drug therapy for ventricular tachyarrhythmias among patients with prior myocardial infarction: the MANTRA-VT randomized trial. [PDF]

open access: yesEuropace
Raatikainen P   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy